CLINICAL TRIALS PROFILE FOR SCOPOLAMINE
✉ Email this page to a colleague
All Clinical Trials for scopolamine
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | Alzheimer's Association | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | Eisai Inc. | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | Pfizer | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
NCT00006399 ↗ | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Completed | National Center for Research Resources (NCRR) | Phase 2 | 1999-09-01 | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for scopolamine
Condition Name
Clinical Trial Locations for scopolamine
Trials by Country
Clinical Trial Progress for scopolamine
Clinical Trial Phase
Clinical Trial Sponsors for scopolamine
Sponsor Name